Alapren Tablets
PDF Leaflet Revision Date: 11 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension and heart failure.
Dosage (summary)
Initial dose: 10-20 mg once daily; elderly: start at 2.5 mg.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity to enalapril
- History of angioedema
- Severe renal impairment
Common side effects
- Hypotension
- Cough
- Dizziness
- Fatigue
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of angioedema
Serious warnings
- Risk of hypotension in volume-depleted patients
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Alapren Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
